Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log-Rank Tests

Authors: Robins, James M.1; Finkelstein, Dianne M.1

Source: Biometrics, Volume 56, Number 3, September 2000 , pp. 779-788(10)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Summary.

AIDS Clinical Trial Group (ACTG) randomized trial 021 compared the effect of bactrim versus aerosolized pentamidine (AP) as prophylaxis therapy for pneumocystis pneumonia (POP) in AIDS patients. Although patients randomized to the bactrim arm experienced a significant delay in time to POP, the survival experience in the two arms was not significantly different (p= .32). In this paper, we present evidence that bactrim therapy improves survival but that the standard intent-to-treat comparison failed to detect this survival advantage because a large fraction of the subjects either crossed over to the other therapy or stopped therapy altogether. We obtain our evidence of a beneficial bactrim effect on survival by artificially regarding the subjects as dependently censored at the first time the subject either stops or switches therapy; we then analyze the data with the inverse probability of censoring weighted Kaplan-Meier and Cox partial likelihood estimators of Robins (1993, Proceedings of the Biopharmaceutical Section, American Statistical Association, pp. 24-33) that adjust for dependent censoring by utilizing data collected on time-dependent prognostic factors.

Keywords: AIDS; Causal inference; Cox proportional hazards model; Informative censoring; Survival analysis; Time-dependent covariates

Document Type: Research article

DOI: 10.1111/j.0006-341X.2000.00779.x

Affiliations: 1: Harvard School of Public Health, 677 Huntington Avenue, Boston, Massachusetts 02115, U.S.A.

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$41.72 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A